4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-027614
EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
- EVP, Research & CSO acquired 2,340 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-19 | Exercise or conversion : show line 1 in the form | +2,340 | $1.53 | $3,580 | 94,040 | D |
| 2021-04-19 | Sale : show line 2 in the form | −2,340 | $48.00 | $112,320 | 91,700 | D |
| Open-market sales · 2,340 sh · avg $48.00 · $112,320 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-19 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −2,340 | 312,155 | D |
Loading xslF345X03/doc4.xml…